How a Biotech Company can achieve efficiency in the management of Clinical Supply Planning?

Who to attend: mid-size Biotech company; Head of Supply, Supply Manager, Supply Planner

Join this discussion to learn ways to proceed and strategies to apply in order to make efficient the supply planning.

Please select the most convinient date

Accurate clinical supply management saves time and money and reduces study risks. In today’s world of uncertainty, it is important to anticipate and analyze potential risks affecting the drug supply, mitigate patient recruitment delays, analyze impact from study changes, and ensure cross-departmental communication.

Join best-in-class experts from S-CLINICA to discuss how to apply an anticipatory approach, when to start and how to proceed in order to identify and mitigate risks and reduce supply drug waste.

You will learn:

  • When to start and how to proceed in order to improve clinical supply planning, reduce costs and anticipate risks
  • Which parameters to consider
  • How to investigate potential scenarios
  • How to analyze the impact on supply management from study changes
  • Why harmonization between Supply forecasting and IRT is important
Irena Seredina
Irena Seredina, M.D., MSc. Executive Director at S-CLINICA
Irena Seredina holds a MD honors diploma and an MSc in Health Economics. During her medical practice, Seredina worked in clinical research as an investigator. The results of her research were published in a number of articles. In 2004, Seredina joined S-CLINICA.

She is currently responsible for customer relationships and strategic business.
Ryoma Collia
Ryoma Collia, Vice President Sales at S-CLINICA

Ryoma Collia is Vice President Sales with over thirty-three years experience bringing solutions to customers at local and global level. Ryoma brings over ten years of experience in Life Sciences, seven of which has been within Clinical Trials.

He is a passionate advocate for patients and clinical sites, and is also very proud to volunteer for and support the Pharmaceutical Contract Management Group as a Steering Committee Member.

error: Content is protected !!